NASA Artemis II’s Christina Koch Reveals 3 Career Rules She Swears By

What does it take to reach the moon? NASA’s Artemis II astronaut Christina Koch shares the three career mantras that shaped her success/

‘The Mandalorian And Grogu’ Not On Summer’s Top 10 Most Anticipated Movies List

The Mandalorian and Grogu is lacking a serious amount of buzz despite being the first new Star Wars movie since 2019.

What Trump’s Executive Order On Ibogaine Means For Veterans With PTSD

Trump signed an executive order to speed ibogaine research for veterans with PTSD. A doctor explains what the science says and what it means for psychedelic therapy.

6 Important Things To Know As Earth Day Approaches

6 critical facts you should know about our changing planet as Earth Day 2026 approaches

China Writes The AI Companion GDPR For A $30B Market

A $30B AI companion market now has its GDPR moment. China’s new rules cover minors, mental health, and data handling, forcing every platform to rebuild compliance fast.

UFC Veteran Retires In The Octagon After Brutal TKO Loss

Gilbert Burns retired after a TKO loss to Mike Malott at UFC Winnipeg — his fifth straight defeat. Here’s his career legacy and what comes next.

The Oil Pipeline Behind Erdoğan’s Anti-Israel Rhetoric

Turkey condemns Israel publicly—but Azerbaijani oil continues flowing through Turkish pipelines to Israeli refineries, exposing the gap between rhetoric and reality.

Why Are Humans Afraid Of The Dark? An Evolutionary Biologist Explains The Ancient Fear We Can’t Shake

By the time you tell yourself there’s nothing in the dark alley, your amygdala has already disagreed. Here’s why, according to evolutionary research.

The Newest Trend In Tech Embraces Femininity And Fun

The female content creators engaging viewers, experimenting with design and stepping away from optimization to develop technology that amplifies joy.

20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs

If the FDA approves a drug for a neglected tropical disease, the company gets a voucher that accelerates review of another drug. This remains controversial.